國立虎尾科技大學 |

Advances in Pharma Business Management and Research = Volume 1 /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Advances in Pharma Business Management and Research/ edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
其他題名:	Volume 1 /
其他作者:	Jansen, Christian.
面頁冊數:	X, 85 p. 11 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacoeconomics and Health Outcomes. -
電子資源:	https://doi.org/10.1007/978-3-030-35918-8
ISBN:	9783030359188

Advances in Pharma Business Management and Research = Volume 1 /
Advances in Pharma Business Management and ResearchVolume 1 /[electronic resource] :edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. - 1st ed. 2020. - X, 85 p. 11 illus.online resource.

Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.

Open Access

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.

ISBN: 9783030359188

Standard No.: 10.1007/978-3-030-35918-8doiSubjects--Topical Terms:

1063577
Pharmacoeconomics and Health Outcomes.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Advances in Pharma Business Management and Research = Volume 1 /
LDR:03298nam a22004335i 4500 001 1025003
003 DE-He213
005 20200701084157.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030359188 $9 978-3-030-35918-8
024 7 $a 10.1007/978-3-030-35918-8 $2 doi
035 $a 978-3-030-35918-8
050 4 $a RS380
050 4 $a RS190-210
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
245 1 0 $a Advances in Pharma Business Management and Research $h [electronic resource] : $b Volume 1 / $c edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a X, 85 p. 11 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
506 0 $a Open Access
520 $a This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 1063577
650 2 4 $a Medical Law. $3 671732
650 2 4 $a Health Care Management. $3 1019864
650 1 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 0 $a Pharmacy management. $3 1236292
650 0 $a Pharmacy. $3 582411
650 0 $a Medical laws and legislation. $3 567375
650 0 $a Health services administration. $3 564005
650 0 $a Health care management. $3 1148454
650 0 $a Pharmaceutical technology. $3 557391
700 1 $a Jansen, Christian. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321205
700 1 $a Russe, Otto Quintus. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321204
700 1 $a Dingermann, Theodor. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321203
700 1 $a Schweizer, Lars. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321202
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030359171
776 0 8 $i Printed edition: $z 9783030359195
776 0 8 $i Printed edition: $z 9783030359201
856 4 0 $u https://doi.org/10.1007/978-3-030-35918-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
912 $a ZDB-2-SOB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)